A single non-thermal atmospheric plasma generation device is used to detect and analyze vital fields of a living subject to determine the presence of a condition, such as an illness or injury, and responsively modify characteristics of the plasma to treat, heal, or alleviate the condition. The device includes a capacitance dielectric discharge array of plasma emitters, and a controller having a power supply, a transformer, and circuit components for driving the transformer at a resonant frequency of the plasma emitters to cause the plurality of plasma emitters to ionize surrounding air and produce the non-thermal plasma. The resonant frequency is around 60 GHz and harmonics thereof. A receiver of the device recovers frequency mixing products from the plasma, which are extracted by signal processing circuitry; signals in the VHF and UHF bands are extracted and analyzed to determine whether signatures of particular vital fields are present.

A sine wave generator includes a resonator circuit, a control circuit and a pulse generator. The resonator circuit is configured to receive energy pulses and to generate a resonator sinusoidal signal responsively to the energy pulses. The control circuit is configured to estimate a signal measure of the resonator sinusoidal signal, or of a signal derived from the resonator sinusoidal signal. The pulse generator is configured to generate the energy pulses responsive to the signal measure estimated by the control circuit, and to drive the resonator circuit with the energy pulses.

A control device includes: a power source configured to supply a high frequency power to a treatment instrument configured to treat a living tissue; a detecting circuit configured to sequentially detect a phase difference between a voltage and a current of the high frequency power supplied to the treatment instrument; and a processor configured to control operation of the power source, the processor being configured to sequentially calculate a variation of the phase difference detected by the detecting circuit, compare the calculated variation of the phase difference with a first threshold set for a variation of a phase difference, and perform reduction processing to reduce output of the high frequency power to be supplied to the treatment instrument when it is determined that the calculated variation of the phase difference is equal to or smaller than the first threshold.

A surgical operation system includes a US signal output section, an HV signal output section, a probe having a treatment section which has an HV signal applied thereto and vibrates by ultrasound, an HV signal main controller that performs feedback control of the HV signal output section based on the HV signal, a US signal main controller that performs feedback control of the US signal output section based on a US signal, and an HV signal auxiliary controller that controls the HV signal output section based on the US signal, and has a response time shorter than that of the HV signal main controller.

Electrode assemblies include segmented electrodes disposed on a catheter. The segmented electrodes can be constructed at the tip of the catheter. Tip electrodes can be constructed from an electrically insulative substrate comprising an inner lumen, an external tip surface, and a plurality of channels extending from the inner lumen to the external tip surface, a plurality of segmented electrodes, and a plurality of spot electrodes. Each of the plurality of segmented electrodes and each of the plurality of spot electrodes can be laterally separated from each other by an electrically non-conductive substrate portion and each of the spot electrodes and each of the segmented electrodes can be electrically coupled to at least one wire or conductor trace.

An electrosurgical system having an ultrasound generator, configured to emit a high-frequency electrical signal, and an ultrasound instrument, including an ultrasound transducer configured to convert the signal into an ultrasound oscillation, wherein the generator is further configured to determine a resonance frequency of the transducer and adapt a frequency of the signal to the resonance frequency, and wherein the generator is further configured to detect a phase position between the current and the voltage of the signal and based on the detected phase position to determine whether the frequency of the signal corresponds to the resonance frequency. To enable the resonance frequency of the transducer to be determined correctly irrespective of component tolerances, the electrosurgical system is characterized in that the generator is configured to consider, during determination of the phase position, correction values, which are or can be stored in a memory of the generator and/or of the instrument.

In combined methods for treating a patient using time-varying magnetic field, treatment methods combine various approaches for aesthetic treatment. A magnetic field generating device is placed proximate to a body region of the patient. The magnetic field generating device generates a time-varying magnetic field with a magnetic flux density in a range of 0.5 to 7 Tesla. The time-varying magnetic field is applied to the body region of the patient in order to cause a contraction of a muscle within the body region. A second therapy may be used by applying one or more of optical waves, radio frequency waves, mechanical waves, negative or positive pressure or heat to the body region of the patient.

An electrosurgical system can include a surgical device configured to adjust energy delivery in accordance with a specified cutting-to-coagulation relationship. The specified cutting-to-coagulation relationship can be determined based at least in part on an impedance or other parameter associated with tissue or an environment at or near the one or more electrodes. The specified cutting-to-coagulation relationship can be determined automatically (e.g., without requiring user input) and adaptively based on the sensing, such as in real-time as the therapy progresses.

Systems and methods for performing and controlling ablation therapy. Examples provide adaptive therapy outputs that allow a user to select among various feedback parameters, parameter limits, and therapy profiles, to be implemented by an ablation system. The ablation system adaptively issues therapy by monitoring one or more feedback parameters to determine changes to make to therapy outputs.

A monitoring, managing and protecting system is provided that includes a monitoring probe working in conjunction with an ablating device. The probe is configured to be positioned in close proximity to a region of non-targeted tissue proximate an ablation site of targeted tissue and to be operatively connected to an electrical response assessment system or component. The probe includes an elongate shaft having proximal and distal ends, with a handle disposed at the proximal end thereof and a tissue monitoring and protecting apparatus disposed at the distal end thereof. The ablating device includes an elongate shaft having proximal and distal ends, with a handle mounted at the proximal end thereof and an ablation element mounted at the distal end thereof. The monitoring probe measures electrical characteristics of the non-targeted tissue and/or of the tissue between the monitoring electrode and the ablation electrode. The electrical response assessment system determines whether the tissue is being damaged based on the electrical measurements. The monitoring, managing and protecting system can notify a practitioner based on the determination, or modify or stop the ablation procedure.